Smithbridge Asset Management Inc/De
Source: SEC Form 13F · as of Mar 2026Smithbridge Asset Management Inc/De holds 12 biotech & pharma companies tracked by BioSniper, totaling $45.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$45.5M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 43,953 | $10.7M |
| NVSNovartis AG | 48,780 | $7.5M |
| ABBVAbbVie Inc. | 31,584 | $6.9M |
| LLYELI LILLY & Co | 6,159 | $5.7M |
| ABTABBOTT LABORATORIES | 46,633 | $4.8M |
| NVONovo Nordisk A/S | 98,990 | $3.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 8,699 | $2.4M |
| ZTSZoetis Inc. | 13,059 | $1.5M |
| MRKMerck & Co., Inc. | 10,518 | $1.3M |
| CORCencora Inc. | 1,841 | $578K |
| ELVElevance Health Inc. | 1,125 | $329K |
| AMGNAMGEN INC | 700 | $246K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.